Eptifibatide (acetate)

• UNSPSC Description:

  Eptifibatide acetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1].

• Target Antigen:

  Integrin

• Type:

  Peptides

• Related Pathways:

  Cytoskeleton

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Purity:

  99.84

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  O=C([C@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC(O)=O)NC(CNC([C@H](CCCCNC(N)=N)N3)=O)=O)=O)N4CCC[C@]4(C(N[C@H](C(N)=O)CSSCCC3=O)=O)[H].CC(O)=O.[x]

• Molecular Weight:

  831.96 (free base)

• References & Citations:

  [1]Gilchrist IC, et al. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. Clin Pharmacokinet. 2003;42(8):703-20.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  Phase 4

• CAS Number:

  881997-86-0